Tyrosine Hydroxylase Deficiency in Three Greek Patients with a Common Ancestral Mutation

被引:16
作者
Pons, Roser [1 ]
Serrano, Mercedes [2 ,3 ]
Ormazabal, Aida [2 ,3 ]
Toma, Claudio [4 ]
Garcia-Cazorla, Angels [2 ,3 ]
Area, Estela [5 ]
Ribases, Marta [6 ]
Kanavakis, Emmanuel [1 ]
Drakaki, Kaliopi [1 ]
Giannakopoulos, Aristotelis [1 ]
Orfanou, Irene [1 ]
Youroukos, Sotiris [1 ]
Cormand, Bru [4 ]
Artuch, Rafael [2 ,3 ]
机构
[1] Univ Athens, Agia Sofia Hosp, Dept Pediat 1, Athens 11527, Greece
[2] St Joan de Deu Hosp, Ctr Biomed Res Rare Dis CIBERER, Dept Neuropediat, Barcelona, Spain
[3] St Joan de Deu Hosp, Ctr Biomed Res Rare Dis CIBERER, Dept Clin Biochem, Barcelona, Spain
[4] Univ Barcelona, Dept Genet, Inst Biomed, Ctr Biomed Res Rare Dis CIBERER, Barcelona, Spain
[5] Columbia Univ, Dept Neurol, New York, NY USA
[6] Vall dHebron Univ Hosp, Dept Psychiat, Barcelona, Spain
关键词
tyrosine hydroxylase; infantile parkinsonism; oculogyric crisis; autonomic dysfunction; founder effect; DOPA-RESPONSIVE DYSTONIA; ACID DECARBOXYLASE DEFICIENCY; POINT MUTATION; CLINICAL-FEATURES; GENE; ENCEPHALOPATHY; PARKINSONISM; DIAGNOSIS;
D O I
10.1002/mds.23002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We present the clinical, biochemical, and molecular findings of three Greek patients with tyrosine hydroxylase (TH) deficiency. All patients presented with a severe clinical phenotype characterized by prominent motor delay, infantile parkinsonism, oculogyric crises, and signs of autonomic dysfunction. Cerebrospinal fluid analysis disclosed reduced dopamine metabolites and normal pterins. Response to levodopa was favorable though not dramatic. All patients were homozygous for a previously reported mutation (p.L236P). SNP haplotype analysis was consistent with a common ancestral mutation, thus indicating a founder effect in Greek patients with TH deficiency. (C) 2010 Movement Disorder Society
引用
收藏
页码:1086 / 1090
页数:5
相关论文
共 25 条
[1]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[2]  
Blau N., 2001, The Molecular and Metabolic Basis of Inherted Disease, P1725
[3]  
Bräutigam C, 1999, CLIN CHEM, V45, P2073
[4]  
Bräutigam C, 1998, CLIN CHEM, V44, P1897
[5]   Tyrosine hydroxylase deficiency unresponsive to L-dopa treatment with unusual clinical and biochemical presentation [J].
De Lonlay, P ;
Nassogne, MC ;
van Gennip, AH ;
van Cruchten, AC ;
de Villemeur, TB ;
Cretz, M ;
Stoll, C ;
Launay, JM ;
Steenberger-Spante, GCV ;
van den Heuvel, LPW ;
Wevers, RA ;
Saudubray, JM ;
Abeling, NGGM .
JOURNAL OF INHERITED METABOLIC DISEASE, 2000, 23 (08) :819-825
[6]   Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections [J].
Diepold, K ;
Schütz, B ;
Rostasy, K ;
Wilken, B ;
Hougaard, P ;
Güttler, F ;
Romstad, A ;
Moller, LB .
MOVEMENT DISORDERS, 2005, 20 (06) :764-767
[7]   Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency [J].
Furukawa, Y ;
Kish, SJ ;
Fahn, S .
ANNALS OF NEUROLOGY, 2004, 55 (01) :147-148
[8]   Dope-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations [J].
Furukawa, Y ;
Graf, WD ;
Wong, H ;
Shimadzu, M ;
Kish, SJ .
NEUROLOGY, 2001, 56 (02) :260-263
[9]   The structure of haplotype blocks in the human genome [J].
Gabriel, SB ;
Schaffner, SF ;
Nguyen, H ;
Moore, JM ;
Roy, J ;
Blumenstiel, B ;
Higgins, J ;
DeFelice, M ;
Lochner, A ;
Faggart, M ;
Liu-Cordero, SN ;
Rotimi, C ;
Adeyemo, A ;
Cooper, R ;
Ward, R ;
Lander, ES ;
Daly, MJ ;
Altshuler, D .
SCIENCE, 2002, 296 (5576) :2225-2229
[10]   Tyrosine hydroxylase deficiency presenting with a Biphasic Clinical Course [J].
Giovanniello, T. ;
Leuzzi, V. ;
Carducci, C. ;
Carducci, C. ;
Di Sabato, M. L. ;
Artiola, C. ;
Santagata, S. ;
Pozzessere, S. ;
Antonozzi, I. .
NEUROPEDIATRICS, 2007, 38 (04) :213-215